Literature DB >> 19535753

Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.

Nuriye Tasdelen Fisgin1, Esra Tanyel, Levent Doganci, Necla Tulek.   

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is a potentially fatal viral disease. In this study, the aim was to investigate the prognostic factors affecting the patient's survival and risk factors to fatality. At Ondokuz Mayis University Faculty of Medicine, a tertiary referral centre near the CCHF epidemic region, patients with typical clinical findings and indicative microbiological results for IgM and/or reverse transcriptase-polymerase chain reaction of CCHF virus were enrolled in the study, from 2004 to 2007. Patients were divided into two subgroups according to their survival outcomes; group I (n = 44) survived patients and group II (n = 6) consisted of fatal cases. The median platelet count was significantly lower in the fatal group (11000/mm(3)) when compared to the survived group (49500/mm(3)). Aspartate transferase and alanine transferase (ALT) levels were significantly higher in group II, when compared to group I. Also, the median range of serum lactic dehydrogenase (LDH) and creatinine phosphokinase (CPK) levels were much more elevated, and prothrombin time (PT) and activated partial thromboplastin time (aPTT) were prolonged in fatal cases. There was also a significant difference in median age of these two groups. Advanced age, late admission, low platelet count, increased AST, ALT, CPK and LDH levels, and prolonged PT and aPTT could be an early indicator of poor prognosis in patients with CCHF.

Entities:  

Mesh:

Year:  2009        PMID: 19535753     DOI: 10.1258/td.2008.080092

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  5 in total

1.  Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF).

Authors:  M Bakır; M G Gözel; I Köksal; Z Aşık; Ö Günal; H Yılmaz; A But; G Yılmaz; A Engin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-12       Impact factor: 3.267

2.  Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever.

Authors:  Nil Guler; Cafer Eroglu; Hava Yilmaz; Adil Karadag; Hasan Alacam; Mustafa Sunbul; Tom E Fletcher; Hakan Leblebicioglu
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

Review 3.  Ribavirin for treating Crimean Congo haemorrhagic fever.

Authors:  Samuel Johnson; Nicholas Henschke; Nicola Maayan; Inga Mills; Brian S Buckley; Artemisia Kakourou; Rachel Marshall
Journal:  Cochrane Database Syst Rev       Date:  2018-06-05

4.  Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections.

Authors:  Meiliang Wang; Jiuping Wang; Tianping Wang; Jing Li; Ling Hui; Xiaoqin Ha
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

5.  Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients.

Authors:  Yunus Gurbuz; Baris Ozturk; Emin Ediz Tutuncu; Irfan Sencan; Gonul Cicek Senturk; Fatma Aybala Altay
Journal:  Jundishapur J Microbiol       Date:  2015-10-20       Impact factor: 0.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.